{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:30:59Z","timestamp":1793669459494,"version":"4.5.1"},"reference-count":63,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"NIH HHS\/United States"},{"name":"NIH HHS\/United States"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/17474086.2024.2356257","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T08:02:40Z","timestamp":1716537760000},"page":"201-210","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma"],"prefix":"10.1080","volume":"17","author":[{"given":"Nathalie","family":"Javidi-Sharifi","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34479"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282632"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0031"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0844"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00510"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17984"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.2020779"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37648-w"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01181"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30443-5"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.2282"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-719294"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO20224016_suppl7539"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000801"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03355"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300696"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-163596"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3164_423"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279158"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280061"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24310"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00371-6"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO20224016_supplTPS7581"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-164772"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3321"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-160386"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-169664"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00687"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1978288"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001160"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17994"},{"key":"e_1_3_4_40_1","doi-asserted-by":"crossref","unstructured":"Byrd JC Woyach JA Furman RR et al. Acalabrutinib in treatment-naive chronic lymphocytic leukemia [Internet]. 2021. Available from: http:\/\/ashpublications.org\/blood\/article-pdf\/137\/24\/3327\/1809937\/bloodbld2020009617.pdf","DOI":"10.1182\/blood.2020009617"},{"key":"e_1_3_4_41_1","doi-asserted-by":"crossref","unstructured":"Byrd JC Wierda WG Schuh A et al. Acalabrutinib monotherapy in patients with relapsed\/refractory chronic lymphocytic leukemia: updated phase 2 results [Internet]. 2020. Available from: http:\/\/ashpublications.org\/blood\/article-pdf\/135\/15\/1204\/1723177\/blood884940.pdf","DOI":"10.1182\/blood.2018884940"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-870238"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.233.233"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.182907"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00884-4"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2164692"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3163_154"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00293-5"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.259432"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005621"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000969428.35688.4b"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01252-y"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13148"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1142"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15690"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006844"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049210"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-742437"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016953"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148544"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213093"},{"issue":"7","key":"e_1_3_4_63_1","article-title":"Fixed-duration ibrutinib-venetoclax in patients with chronic lymphocytic leukemia and comorbidities","volume":"1","author":"Kater AP","year":"2022","unstructured":"Kater AP, Owen C, Moreno C, et al. Fixed-duration ibrutinib-venetoclax in patients with chronic lymphocytic leukemia and comorbidities. NEJM Evidence [Internet]. 2022 [cited 2023 Oct 11];1(7). Available from: https:\/\/evidence.nejm.org\/doi\/full\/10.1056\/EVIDoa2200006","journal-title":"NEJM Evidence [Internet]"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3163_153"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2024.2356257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:25:13Z","timestamp":1727277913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2024.2356257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/17474086.2024.2356257"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2024.2356257","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}